Menu
Blog Banner Image

PFAS Playbook

PFAS Playbook

  • Posts by Arielle B. McPherson
    Associate

    Arielle McPherson is an associate who focuses her practice on environmental, product liability and tort litigation. She is involved in all phases of litigation, including discovery, depositions, dispositive and pre-trial ...

Last month, the EPA issued the Fifth Unregulated Contaminant Monitoring Rule (UCMR 5) to establish nationwide monitoring for 29 per- and polyfluoroalkyl substances (PFAS) and lithium in drinking water. The Safe Drinking Water Act mandates the EPA to monitor for unregulated contaminants in drinking water every 5 years. Under the UCMR 5, public water systems will collect data on 29 PFAS over a 12-month period from 2023 through 2025 with a report of final results in 2026. The UCMR 5 testing requirement will apply to public water systems serving over 10,000 people; all systems serving ...

Email LinkedIn Twitter Facebook

In an August 5th letter to the food packaging industry, the U.S. Food and Drug Administration (FDA) issued a reminder to manufacturers, distributors, and users of fluorinated polyethene food packaging of the limitations of fluorinated polyethylene containers that are authorized for food contact use. The FDA also reminded the food packaging industry that the manufacturing of such packaging must be made under specific conditions and in compliance with existing FDA regulations.

The FDA’s letter comes in the wake of recent testing performed by the Environmental Protection ...

Email LinkedIn Twitter Facebook

United States Senator, Kristin Gillibrand (D-NY), along with other House and Senate Democrats, recently announced new legislation targeted at addressing per- and polyfluoroalkyl substances (“PFAS”) contamination. The proposed PFAS Accountability Act, which has not yet been released, would establish a federal cause of action allowing individuals who have been exposed to PFAS to sue companies that manufacture or use the chemicals. Senator Gillibrand’s legislation will also provide legal pathways for federal courts to set up medical monitoring programs for ...

Email LinkedIn Twitter Facebook

About this Blog

Lathrop GPM has deep experience developing regulatory strategy and defending litigation in the area of per- and polyfluoroalkyl substances (PFAS), and we have been involved in some of the nation’s most-publicized cases. The PFAS Playbook blog is dedicated to helping readers stay up to date and understand the latest regulatory updates on PFAS. 

Topics

Archives

Blog Authors

Recent Posts